Dashboard
Manage Tickers

IRWD


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

leerink-partners-initiates-coverage-on-ironwood-pharmaceuticals-with-market-perform-rating-announces-price-target-of-5
Leerink Partners Initiates Coverage On Iro...
09/09/2024 12:55:32

Leerink Partners analyst Faisal Khurshid initiates coverage on Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Market Perform ...

wells-fargo-maintains-overweight-on-ironwood-pharmaceuticals-lowers-price-target-to-12
Wells Fargo Maintains Overweight on Ironwo...
08/09/2024 22:30:45

Wells Fargo analyst Mohit Bansal maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Overweight and lowers the price tar...

craig-hallum-maintains-buy-on-ironwood-pharmaceuticals-lowers-price-target-to-10
Craig-Hallum Maintains Buy on Ironwood Pha...
08/09/2024 16:17:19

Craig-Hallum analyst Chase Knickerbocker maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Buy and lowers the price ta...

ironwood-has-revised-its-fy-2024-financial-guidance-due-to-continued-linzess-pricing-pressure-due-to-higher-than-expected-medicaid-utilization-trends-for-fy-2024-it-expects-sales-of-350m-375m-compared-to-prior-range-of-405m-425m-and-consensus-of-41005m
Ironwood Has Revised Its FY 2024 Financial...
08/08/2024 11:08:13

Prior 2024 Guidance (May 9, 2024)Revised 2024 Guidance (August 8, 2024)U.S. LINZESS Net SalesMid-single digits % decline2Total ...

ironwood-pharmaceuticals-q2-2024-adj-eps-000-misses-015-estimate-sales-94396m-miss-106996m-estimate
Ironwood Pharmaceuticals Q2 2024 Adj. EPS ...
08/08/2024 11:03:41

asana-clover-health-investments-hertz-global-and-other-big-stocks-moving-higher-on-friday
Asana, Clover Health Investments, Hertz Gl...
06/21/2024 14:45:13

ironwood-pharmaceuticals-appoints-sravan-k-emany-as-senior-vice-president-chief-operating-officer-and-chief-financial-officer-emany-previously-served-as-senior-vice-president-cfo-since-december-2021
Ironwood Pharmaceuticals Appoints Sravan K...
06/20/2024 20:13:46

- Form8

ironwood-pharmaceuticals-will-present-late-breaking-data-during-the-2024-digestive-disease-week-meeting-from-its-phase-3-stars-trial-of-apraglutide-for-short-bowel-syndrome-with-intestinal-failure
Ironwood Pharmaceuticals Will Present Late...
05/21/2024 10:13:47

New data highlight both stoma and colon-in-continuity (CIC) patients drove the positive primary endpoint with significant rel...

craig-hallum-maintains-buy-on-ironwood-pharmaceuticals-lowers-price-target-to-14
Craig-Hallum Maintains Buy on Ironwood Pha...
05/10/2024 16:26:45

Craig-Hallum analyst Chase Knickerbocker maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Buy and lowers the price ta...

why-duolingo-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Duolingo Shares Are Trading Lower By A...
05/09/2024 17:57:05

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 12:06:31

ironwood-pharmaceuticals-lowers-2024-guidance-now-expects-sales-between-405m-425m-prior-435m-455m-vs-4479m-consensus-sees-adjusted-ebitda-above-120m
Ironwood Pharmaceuticals Lowers 2024 Guida...
05/09/2024 11:31:10

Ironwood 2024 Financial Guidance. Ironwood has revised its FY 2024 financial guidance due to a LINZESS gross-to-net change in...

ironwood-pharmaceuticals-q1-2024-adj-eps-002-misses-019-estimate-sales-74877m-miss-105804m-estimate
Ironwood Pharmaceuticals Q1 2024 Adj EPS $...
05/09/2024 11:14:05

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly losses of $(0.02) per share which missed the analyst consensus estima...

ironwood-pharmaceuticals-announces-results-from-phase-2-exploratory-stargaze-trial-of-apraglutide-for-steroid-refractory-gastrointestinal-acute-graft-versus-host-disease
Ironwood Pharmaceuticals Announces Results...
03/28/2024 11:33:10

First prospective trial of a glucagon-like peptide (GLP-2) analog in SR GI aGVHD. Results up to Day 91 show that apraglutide...

top-3-health-care-stocks-that-could-lead-to-your-biggest-gains-in-march
Top 3 Health Care Stocks That Could Lead T...
03/07/2024 12:18:46

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

wells-fargo-maintains-overweight-on-ironwood-pharmaceuticals-lowers-price-target-to-14
Wells Fargo Maintains Overweight on Ironwo...
03/01/2024 18:00:24

Wells Fargo analyst Mohit Bansal maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Overweight and lowers the price tar...

why-butterfly-network-shares-are-trading-lower-by-22-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Butterfly Network Shares Are Trading L...
02/29/2024 19:00:01

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed four...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
02/29/2024 17:32:04

why-is-gastrointestinal-healthcare-focused-ironwood-pharmaceuticals-stock-sinking-on-thursday
Why Is Gastrointestinal Healthcare Focused...
02/29/2024 16:34:52

Ironwood Pharmaceuticals' SBS-IF treatment Apraglutide's Phase 3 trial met primary endpoints, reducing PS dependency by...

nasdaq-gains-100-points-following-pce-data
Nasdaq Gains 100 Points Following PCE Data
02/29/2024 15:40:00

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION